TOP1 and neoplasm: Combination of Top1 poisons with immunotherapies is further supported by evidence that in breast cancer cells Topotecan induces IFN I signalling and upregulation of class I MHC genes [133], a potential mechanism for immune sensitization of tumours deficient of MHC antigens on membrane surface.